Results 81 to 90 of about 5,679 (109)
Some of the next articles are maybe not open access.

Related searches:

Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the 'Ph1-negative Myeloproliferative Neoplasms Latium Group'.

European Journal of Haematology, 2020
BACKGROUND AND AIMS Anagrelide is a drug effective in reducing platelet counts in Essential Thrombocythemia (ET) and Ph1-negative Myeloproliferative Neoplasms.
M. Mazzucconi   +18 more
semanticscholar   +1 more source

Rheological Properties and Microstructure of PH1 Stainless Steel Produced by Selective Laser Melting

Materials Science Forum, 2020
The present study is focused on rheological properties of PH1 stainless steel, produced by selective laser melting (SLM), at temperatures of hot deformation, with the aim to investigate the dependence of strain resistance on temperature and strain degree.
S. Gladkovskii   +4 more
semanticscholar   +1 more source

Accumulation of ph1 (zip4-5B) and ph2 (msh7-3D) mutations fails to boost homoeologous recombination in hexaploid wheat

bioRxiv
Diversification of the hexaploid (bread) wheat genetic pool using wild genetic resources relies on effective meiotic recombination (crossover) between wheat chromosomes and their counterparts from related species (homoeologues).
Camille Haquet   +7 more
semanticscholar   +1 more source

Blinatumomab + Ponatinib for Relapsed Ph1-Positive Acute Lymphoblastic Leukemia: The French Experience

Blood, 2018
Prognosis of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph1+ ALL) has been considerably improved since the beginning of the BCR-ABL1 tyrosine kinase inhibitors (TKI) era 20 years ago.
M. Couturier   +7 more
semanticscholar   +1 more source

Successful kidney-alone transplantation in a patient with PH1 on combination RNA-interference therapy.

Kidney International, 2023
Elisabeth L. Metry   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy